Literature DB >> 12164372

Cushing's syndrome caused by topical steroid therapy for psoriasis.

E M Abma1, R Blanken, L J M De Heide.   

Abstract

A 72-year-old woman developed manifestations of Cushing's syndrome after long-term topical steroid therapy for psoriasis. Shortly after tapering the dose of topical steroids she developed signs of adrenal insufficiency (provoked by a urinary tract infection) requiring intravenous administration of a stress dose of hydrocortisone. There have only been a few reports of systemic side effects of topically applied corticosteroids in adults. Considering their serious consequences physicians should be alert to signs of Cushing's syndrome in patients on long-term topical steroid therapy. Furthermore, clobetasol propionate ointment doses exceeding 50 g a week should not be prescribed and use of occlusive dressings should be avoided.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164372

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  11 in total

Review 1.  Drugs and HPA axis.

Authors:  Alberto Giacinto Ambrogio; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  Steroid swapping between friends: adrenal suppression secondary to psoriasis treatment.

Authors:  R Hughes; J Gibney; B Kirby
Journal:  Ir J Med Sci       Date:  2008-11-07       Impact factor: 1.568

3.  Topical corticosteroids and the risk of diabetes mellitus: a nested case-control study in the Netherlands.

Authors:  Michiel W van der Linden; Fernie J A Penning-van Beest; Tamar Nijsten; Ron M C Herings
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

4.  Psoriatic erythroderma and hypothalamus-pituitary axis suppression due to misuse of systemic steroid: two challenging cases.

Authors:  Gautam K Singh; Manas Chatterjee
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

5.  Topical steroid-induced Cushing syndrome.

Authors:  Sultan Al-Khenaizan; Ibrahim Al Alwan
Journal:  Ann Saudi Med       Date:  2008 Jul-Aug       Impact factor: 1.526

6.  Infantile Iatrogenic Cushing Syndrome due to Topical Steroids.

Authors:  Lulwah Alkhuder; Horia Mawlawi
Journal:  Case Rep Pediatr       Date:  2019-12-02

7.  Ameliorative Effect Of Zinc Oxide Nanoparticles Against Dermal Toxicity Induced By Lead Oxide In Rats.

Authors:  A A Khalaf; Eman I Hassanen; Rehab A Azouz; Amr R Zaki; Marwa A Ibrahim; Khaled Y Farroh; Mona K Galal
Journal:  Int J Nanomedicine       Date:  2019-09-20

8.  Novel Predictive Model for Adrenal Insufficiency in Dermatological Patients with Topical Corticosteroids Use: A Cross-Sectional Study.

Authors:  Suporntip Hintong; Phichayut Phinyo; Mati Chuamanochan; Mattabhorn Phimphilai; Worapaka Manosroi
Journal:  Int J Gen Med       Date:  2021-11-12

9.  A Florid Case of Iatrogenic Cushing's Syndrome Induced by Topical Steroid with Osteoporosis and Hypogonadism.

Authors:  Pranab Kumar Sahana; Nilendu Sarma; Nilanjan Sengupta; Prashant Subhash Somani
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

10.  Early efficacy and safety data with fixed-dose combination calcipotriol/betamethasone dipropionate foam attributed to mechanism of absorption and steroid potency.

Authors:  Y Tada; L Iversen; J Koo
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-02       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.